355 related articles for article (PubMed ID: 29363044)
1. Reactive Astrocytes in Glioblastoma Multiforme.
Guan X; Hasan MN; Maniar S; Jia W; Sun D
Mol Neurobiol; 2018 Aug; 55(8):6927-6938. PubMed ID: 29363044
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal transition and increased therapy resistance of glioblastoma cells is related to astrocyte reactivity.
Niklasson M; Bergström T; Jarvius M; Sundström A; Nyberg F; Haglund C; Larsson R; Westermark B; Segerman B; Segerman A
J Pathol; 2019 Nov; 249(3):295-307. PubMed ID: 31298733
[TBL] [Abstract][Full Text] [Related]
3. Glioblastoma multiforme-derived extracellular vesicles drive normal astrocytes towards a tumour-enhancing phenotype.
Oushy S; Hellwinkel JE; Wang M; Nguyen GJ; Gunaydin D; Harland TA; Anchordoquy TJ; Graner MW
Philos Trans R Soc Lond B Biol Sci; 2018 Jan; 373(1737):. PubMed ID: 29158308
[TBL] [Abstract][Full Text] [Related]
4. Novel insights into astrocyte-mediated signaling of proliferation, invasion and tumor immune microenvironment in glioblastoma.
Zhang H; Zhou Y; Cui B; Liu Z; Shen H
Biomed Pharmacother; 2020 Jun; 126():110086. PubMed ID: 32172060
[TBL] [Abstract][Full Text] [Related]
5. EMT-like process in glioblastomas and reactive astrocytes.
Iser IC; Lenz G; Wink MR
Neurochem Int; 2019 Jan; 122():139-143. PubMed ID: 30496766
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma quo vadis: Will migration and invasiveness reemerge as therapeutic targets?
Lefranc F; Le Rhun E; Kiss R; Weller M
Cancer Treat Rev; 2018 Jul; 68():145-154. PubMed ID: 30032756
[TBL] [Abstract][Full Text] [Related]
7. Astrocytes, the rising stars of the glioblastoma microenvironment.
Brandao M; Simon T; Critchley G; Giamas G
Glia; 2019 May; 67(5):779-790. PubMed ID: 30240060
[TBL] [Abstract][Full Text] [Related]
8. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment.
Hoelzinger DB; Demuth T; Berens ME
J Natl Cancer Inst; 2007 Nov; 99(21):1583-93. PubMed ID: 17971532
[TBL] [Abstract][Full Text] [Related]
9. Collective invasion of glioma cells through OCT1 signalling and interaction with reactive astrocytes after surgery.
Kim Y; Lee D; Lawler S
Philos Trans R Soc Lond B Biol Sci; 2020 Sep; 375(1807):20190390. PubMed ID: 32713306
[TBL] [Abstract][Full Text] [Related]
10. Glioma-astrocyte interactions on white matter tract-mimetic aligned electrospun nanofibers.
Grodecki J; Short AR; Winter JO; Rao SS; Winter JO; Otero JJ; Lannutti JJ; Sarkar A
Biotechnol Prog; 2015; 31(5):1406-15. PubMed ID: 26081199
[TBL] [Abstract][Full Text] [Related]
11. Direct-Contact Co-culture of Astrocytes and Glioblastoma Cells Patterned using Polyelectrolyte Multilayer Templates.
Stanke KM; Kidambi S
J Vis Exp; 2022 Jun; (184):. PubMed ID: 35815979
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoids promote a glioma stem cell-like phenotype and resistance to chemotherapy in human glioblastoma primary cells: Biological and prognostic significance.
Kostopoulou ON; Mohammad AA; Bartek J; Winter J; Jung M; Stragliotto G; Söderberg-Nauclér C; Landázuri N
Int J Cancer; 2018 Mar; 142(6):1266-1276. PubMed ID: 29067692
[TBL] [Abstract][Full Text] [Related]
13. Tumoral RANKL activates astrocytes that promote glioma cell invasion through cytokine signaling.
Kim JK; Jin X; Sohn YW; Jin X; Jeon HY; Kim EJ; Ham SW; Jeon HM; Chang SY; Oh SY; Yin J; Kim SH; Park JB; Nakano I; Kim H
Cancer Lett; 2014 Oct; 353(2):194-200. PubMed ID: 25079688
[TBL] [Abstract][Full Text] [Related]
14. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
Li Q; Dong C; Cui J; Wang Y; Hong X
J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
[TBL] [Abstract][Full Text] [Related]
15. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
[TBL] [Abstract][Full Text] [Related]
16. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
17. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
[TBL] [Abstract][Full Text] [Related]
18. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
[TBL] [Abstract][Full Text] [Related]
19. Piperlongumine selectively kills glioblastoma multiforme cells via reactive oxygen species accumulation dependent JNK and p38 activation.
Liu JM; Pan F; Li L; Liu QR; Chen Y; Xiong XX; Cheng K; Yu SB; Shi Z; Yu AC; Chen XQ
Biochem Biophys Res Commun; 2013 Jul; 437(1):87-93. PubMed ID: 23796709
[TBL] [Abstract][Full Text] [Related]
20. Malignant gliomas induce and exploit astrocytic mesenchymal-like transition by activating canonical Wnt/β-catenin signaling.
Lu P; Wang Y; Liu X; Wang H; Zhang X; Wang K; Wang Q; Hu R
Med Oncol; 2016 Jul; 33(7):66. PubMed ID: 27236327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]